Heart failure with reduced ejection fraction, Renal impairment research hub

A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With Renal Impairment Using Positron Emission Tomography (PET)

This study is looking at a new medicine called AZD3427 for people with heart failure and kidney problems. It uses special scans to see if the medicine improves blood flow in the kidneys over 8 days. Doctors want to know if it's safe and how well it helps.